AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016
May 17, 2016
30583_dirs_2016-05-17_71ebcd77-d851-4650-ae0c-b9a714f40595.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-04-29
Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-29 | Common Stock | A | 202 | $51.264 | Acquired | 64135 | Direct |
| 2016-05-13 | Common Stock | F | 1722 | $82.710 | Disposed | 62413 | Direct |
Footnotes
F1: The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2015 to April 30, 2016.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19